Abstract
Polyethylene glycol (PEG)-stabilized lipid microbubbles (MBs) are promising ultrasound-responsive drug delivery platforms; however, their optimization remains largely empirical and fails to resolve the interfacial mechanisms governing drug adsorption and stability. Here, we established a thermodynamics-guided framework to determine how PEG grafting density, spanning mushroom to brush conformational regimes, regulates drug adsorption in anionic lipid MBs. Using doxorubicin (DOX) as a model drug, loading was quantified across macroscopic, mesoscopic, and microscopic descriptors, while adsorption energetics were evaluated through apparent Gibbs free energy (ΔGapp), enthalpic (ΔHapp) and entropic (ΔSapp) contributions. Surface-normalized loading (DOXmolecules/μm2) emerged as the most predictive descriptor of intrinsic apparent adsorption energetics, minimizing geometric and population-dependent variability across formulations. Increasing anionic lipid and PEG content progressively shifted adsorption from thermodynamically unfavorable to favorable regimes, accompanied by increasingly negative ΔGapp, interactions–SA values (from 4.6 ± 0.2 to −1.3 ± 0.9 kJ/mol). Mushroom architectures were dominated by hydrophobic interactions (56.0 ± 4.9%), intermediate regimes exhibited the strongest electrostatic contributions (77.1 ± 21.0%), whereas brush architectures promoted DOX–DOX π–π-dominated adsorption (78.9 ± 5.0%). Temperature-dependent studies revealed predominantly ΔHapp,SA-driven adsorption, with brush architectures exhibiting the strongest thermodynamic stabilization (ΔHapp,SA= −27.8 ± 4.0 kJ/mol). Correspondingly, brush MBs achieved up to 6.2 ± 1.5 × 106 DOXmolecules/μm2 without aggregation, representing ∼7.8-fold and ∼3.9-fold higher surface loading than mushroom and intermediate architectures, respectively. Together, these findings establish PEG architecture as a dominant regulator of adsorption energetics and loading behavior, providing predictive and rational design principles for engineering ultrasound-responsive MB drug delivery systems.


1. Introduction
Polyethylene glycol (PEG)-stabilized lipid microbubbles (MBs) are gas-filled microspheres, typically 1–10 μm in diameter, that have evolved from contrast-enhanced ultrasound (US) imaging agents into multifunctional platforms for molecular imaging and image-guided drug delivery. , This transition has been driven by the incorporation of therapeutic payloads and targeting ligands, enabling controlled spatiotemporal release through acoustic cavitation. − Current drug-loading strategies include covalent conjugation via PEG linkers, , electrostatic and hydrophobic adsorption, , and biotin–avidin coupling. ,
Despite their widespread application, the characterization of drug-loaded MBs remains largely empirical, relying predominantly on macroscopic descriptors such as encapsulation efficiency and bulk yield. − Although useful for initial formulation screening, these metrics reduce optimization to maximizing payload incorporation while overlooking the interfacial forces governing drug retention and stability. Consequently, formulation performance is frequently evaluated through storage stability , and US-triggered release profiles, , approaches that confirm functionality but remain fundamentally phenomenological. As a result, MB design remains constrained to a trial-and-error paradigm. Addressing this limitation requires frameworks capable of directly resolving interfacial loading energetics and the molecular interactions governing payload adsorption at the gas-liquid interface. Such mechanistic insight is essential to predict payload stability under dynamic physiological conditions and to enable the rational design of next-generation MB systems.
In pharmaceutical science and surface chemistry, thermodynamic analysis provides a rigorous framework for predictive, energy-based design and underpins the development of advanced drug delivery systems. Quantitative determination of the Gibbs free energy (ΔG), enthalpy (ΔH), and entropy (ΔS) enables mechanistic resolution of adsorption processes by distinguishing enthalpy-driven interactions from entropic contributions associated with desolvation and interfacial reorganization. , Leveraging these principles enables the rational engineering design of drug carriers with enhanced efficacy, specificity, and safety. , Hydrophobic and electrostatic interactions are particularly attractive for loading small molecules because they permit reversible association while preserving efficient US-triggered release. Within this context, doxorubicin (DOX), a widely used chemotherapeutic agent, serves as both a clinically relevant MB payload ,− and a model probe for investigating MB interfacial behavior. Its cationic, amphiphilic structure promotes strong and reproducible interactions with charged lipid monolayers, ,, while its adsorption is highly sensitive to variations in shell composition and interfacial free energy. This sensitivity provides a powerful platform for quantifying the molecular-scale interactions governing payload adsorption and interfacial stability.
To balance DOX loading capacity with therapeutic performance, MB formulations typically combine zwitterionic phospholipids for structural integrity, anionic lipids for electrostatic regulation, and PEGylated lipids for steric stabilization. ,,− Although the influence of anionic lipid composition on DOX loading , and acoustic response, , is well-established, the role of PEG architecture remains poorly understood. PEG is not merely a passive stabilizer but a dominant regulator of interfacial structure and mechanics. As PEG grafting density and molecular weight increase, tethered chains undergo a conformational transition from sparsely distributed mushroom regimes to densely packed brush layers. − This transition modulates shell elasticity, suppresses coalescence, and alters MB acoustic behavior. ,−
Although PEGylation is conventionally employed to prolong circulation time by reducing protein adsorption, , recent studies demonstrates that PEG can paradoxically enhance immunogenicity and accelerate MB clearance. We recently showed that PEG architecture actively reprograms MB pharmacokinetics, where mushroom-like coatings prolong circulation while dense brush layers promote rapid clearance via complement activation. Increasing PEG surface densities further induces thermodynamically driven lateral phase separation within lipid monolayers, generating interfacial domains that may spatially regulate drug adsorption. Collectively, these findings identify PEG architecture as a key regulator of interfacial thermodynamics, adsorption pathways, and drug-loading behavior.
Here, we aimed to establish a thermodynamics-guided framework to elucidate how PEG organization governs drug adsorption and loading in anionic lipid MBs. By systematically varying PEG grafting density across mushroom, intermediate and brush conformational regimes, we quantified the Gibbs free energy and its enthalpic and entropic contributions governing DOX adsorption across macroscopic, mesoscopic, and microscopic interfacial length scales. We further evaluated how drug concentration and incubation time modulate adsorption within distinct PEG architectures, establishing a direct mechanistic relationship between shell organization, adsorption energetics, and tunable loading performance.
2. Materials and Methods
2.1. Materials
Dipalmitoyl-sn-glycero-3-phosphocholine (DPPC), 1,2-dipalmitoyl-sn-glycero-3-phospho-l-serine (sodium salt; DPPS), dextrose, chloroform, glycerol, and propylene glycol were purchased from Sigma-Aldrich (St. Louis, MO, USA). The PEGylated lipid 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000] (DSPE-mPEG2000) was acquired from NOF America Corporation (White Plains, NY, USA). Perfluorobutane gas (C4F10, PFB) was obtained from FluoroMed (Round Rock, TX, USA). Medical-grade doxorubicin hydrochloride (ZUCLODOXMR, DOX) was obtained from Zurich Pharma S.A. de C.V. (Tepeji del Río, Hidalgo,México). All reagents were used as received and possessed a purity ≥99%.
2.2. Theoretical Classification of PEG Shell Architectures
MB shell architectures were systematically engineered to generate mushroom, intermediate, and brush PEG conformational regimes by varying the molar fraction of DSPE-mPEG2000 (χPEG), as previously described. PEG conformations were assigned according to the classical Alexander–de Gennes polymer brush theory, in which chain organization is governed by the balance between the Flory radius (RF) and the average inter-chain distance (D). RF represents the characteristic size of an isolated PEG chain in a good solvent, whereas D corresponds to the mean spacing between neighboring grafting sites and is related to the PEG grafting density (σ), defined as the number of grafted PEG chains per unit of surface area. Assuming a homogeneous PEG-lipid distribution, σ is given by σ = χPEG/Alipid, , yielding:
| 1 |
PEG conformational regimes were determined by the relative magnitude of D and RF, with mushroom (D > RF), intermediate (D ≈ RF), and brush (D < RF) regimes. − Accordingly, χPEG values of 0.01, 0.05, and 0.10 correspond to mushroom, intermediate, and brush conformational regimes, respectively (Table ).
1. Theoretical PEG Configuration Parameters for Engineered MB Shells.
| χPEG | D (nm) | L (nm) | Architecture |
|---|---|---|---|
| 0.01 | 6.7 | 2.2 | Mushroom |
| 0.05 | 3.0 | 3.8 | Intermediate |
| 0.10 | 2.1 | 4.7 | Brush |
Structural parameters were calculated as follows:
| 2 |
| 3 |
| 4 |
where a is the PEG monomer length (0.35 nm), N is the number of monomers per chain (45 for PEG2000). Alipid is the average cross-sectional area of the lipid headgroups in the gel phase (0.452 nm2), obtained from reported values for DPPC (0.473 nm2), DPPS (0.442 nm2) and DSPE (0.440 nm2). − L denotes the mean height of grafted PEG chains above the interface. Calculated values of RF, D, and L are summarized in Table .
2.3. Preparation of Anionic PEGylated MBs
Anionic PEGylated C4F10 gas-core MBs were prepared by mechanical agitation as previously described. , Lipid shells consisted of DPPC, DPPS and DSPE-mPEG2000. Surface charge and polymer architecture were independently tuned by varying the molar fractions of DPPS (χDPPS) and PEG (χPEG), respectively, as summarized in Table .
2. Lipid Shell Compositions of Engineered MBs.
| χPEG | χDPPS | χDPPC | ||||||
|---|---|---|---|---|---|---|---|---|
| 0.01 | 0.00 | 0.10 | 0.20 | 0.40 | 0.99 | 0.89 | 0.79 | 0.59 |
| 0.05 | 0.00 | 0.20 | 0.30 | 0.40 | 0.95 | 0.75 | 0.65 | 0.55 |
| 0.10 | 0.00 | 0.20 | 0.30 | 0.40 | 0.90 | 0.70 | 0.60 | 0.50 |
Briefly, individual lipids components were dissolved in their respective organic solvents: DPPC and DSPE-mPEG2000 in chloroform and DPPS in chloroform/methanol (2:1, v/v). Then, the lipids were combined at the desired molar ratios (Table ), and the solvent was evaporated under a gentle nitrogen stream. Residual solvent was eliminated under vacuum for 2 h to obtain dry lipid films. The resulting lipid films were hydrated in phosphate-buffered saline (PBS, pH 7.4) containing glycerol and propylene glycol (80:10:10 v/v) at 60 °C for 40 min to achieve a final total lipid concentration of 2.0 mg/mL. Subsequently, 0.5 mL of the liposomal suspension was transferred to a 1.5 mL glass vials, sealed, degassed and refilled with C4F10 gas for 10 s. Polydisperse MB suspensions were generated using an Ultramat S dental amalgamator (SDI, Effingham, IL, USA) operated at 4500 osc/s for 46 s. Immediately after activation, the MB suspension was transferred to sealed 0.65 mL microcentrifuge tubes for purification. Excess lipids and emulsifiers were removed by a single centrifugation step (300 × g, 10 min). Following centrifugation, the lower aqueous phase (subnatant) was carefully removed, and the floating MB cake was collected and stored at 4 °C no longer than 1 h prior to further use.
2.4. Preparation of DOX-Loaded MBs
DOX-loaded MBs (DOX–MBs) were prepared by incubating preformed anionic PEGylated MBs with freshly reconstituted DOX solution in non-degassed sterile water (2 mg/mL, pH = 8.2). The DOX loading procedure was adapted from a previously reported formulations. , Prior to loading, the DOX stock solution was diluted with sterile water containing 5 mg/mL dextrose to obtain a final DOX concentration of 0.5 mg/mL. The collected MB cake of each PEGylated MB formulation was then resuspended in 150 μL of the diluted DOX solution and incubated under gentle rotational agitation for 10 min. The following experimental protocols were designed to resolve the thermodynamic mechanisms governing DOX adsorption:
1) Baseline adsorption and apparent Gibbs free energy (ΔGapp): Baseline adsorption was defined as the amount of DOX adsorbed onto each anionic PEGylated formulation (Table ) under the reference condition of 25 °C (298.15 K). These values were quantified from the DOX loading measurements obtained under the standard loading condition (0.5 mg/mL DOX and 10 min incubation) using the loading descriptors described in Section . The resulting baseline adsorption values were used as reference data for the calculation of ΔGapp, as described in Section .
2) Apparent enthalpic (ΔHapp) and entropic (ΔSapp) contributions: To evaluate the temperature dependence of adsorption, the baseline adsorption protocol was independently performed at 4 °C (277.15 K) and 37 °C (310.15 K), representing relevant storage and physiological conditions, respectively.
Following incubation, DOX–MB suspensions were washed three times by centrifugation (300 × g, 5 min) to remove unbound or weakly associated DOX remaining in the surrounding medium. Three washing cycles were applied until the absorbance values of the supernatant reached levels comparable to sterile water, minimizing the contribution of residual free DOX to the colorimetric measurement. Samples were subsequently resuspended in 150 μL of non-degassed sterile water and transferred to 0.2 mL microcentrifuge tubes under ambient air headspace. Samples were stored at 4 °C for no longer than 1 h prior to microscopic and spectrophotometric characterization to minimize potential changes in DOX–MB properties.
2.5. Characterization of DOX–MBs
DOX–MB suspensions were diluted 1:100 in buffer and loaded into a Neubauer counting chamber (Hausser Scientific, Horsham, PA, USA). Following our previously reported methodology, , for each independent batch, four microscopy images were acquired from each of the four Neubauer quadrants using an Olympus BX51TF microscope equipped with a 50× objective and a Photron FastCAM SA3 camera (Tokyo, Japan). Each image was acquired at a resolution of 768 × 768 pixels and encompassed a field of view equivalent to a single counting square within the Neubauer quadrant. A total of 16 images were collected, corresponding to the standard counting area of one complete Neubauer quadrant. Image analysis was performed using ImageJ software (National Institutes of Health, Bethesda, MD, USA). Images were processed using a kernel convolution and convolution filters to identify MB structures. After binarization, particles were sized and quantified using the Analyze particles script, applying a circularity threshold of >0.5 for individual MBs and <0.5 for agglomerates.
MB concentration (CMB) was determined by microscopic analysis using the Neubauer chamber rule ( . To evaluate DOX adsorption independently of variations in the initial CMB, raw number-weighted size distributions were normalized to a reference concentration (Cref = 1 × 1010 MBs/mL), as previously proposed to facilitate direct comparisons among MB formulations. , The mean-weighted diameter (Dm) and the standard deviation (SD) were calculated from the normalized particle number distributions.
To determine the SA distributions, individual MB diameters (d i ) were converted to surface areas . The normalized number-weighted size distribution was then transformed into a SA distribution by calculating SA contribution of each interval as SA(s) = N(s) × s, where N (s) is the normalized particle number corresponding to a given MB surface area (MBSA). The cumulative interfacial SA available for adsorption (SAnormalized) was calculated as the area under the SA distribution:
| 5 |
2.6. Determination of Encapsulated Drug and Loading Descriptors
Encapsulated DOX was quantified using an adapted version of our previously reported method. − A DOX standard curve (0.0–1.0 mg/mL) was prepared in sterile water prior to analysis. DOX–MBs were disrupted by US exposure for 60 s using an ultrasonic bath (Fisher Scientific FS30, Pittsburgh, PA, USA) to release encapsulated drug. Samples were transferred into 96-well plates (Costar, Corning, NY, USA) and absorbance was measured at 496 nm using a microplate reader (BioTek Instruments ELx800, Winooski, VT, USA). Sterile water served as the blank control, and disrupted unloaded MBs were used to assess background absorbance from MB lipid components. Encapsulation efficiency (EE%) was calculated as
| 6 |
To establish a multi-scale adsorption framework, drug loading was quantified at macroscopic (encapsulated mass, DOXmass), mesoscopic (molecules per MB, DOXmolecules/MB), and microscopic (surface density, DOXmolecules/μm2) scales. All descriptors were normalized to a Cref of 1 × 1010 MBs/mL. The descriptors were calculated as follows:
| 7 |
| 8 |
| 9 |
where MDOX/mL is the detected mass of DOX per mL, CMB is the measured MBs concentration, NA is Avogadro’s number (NA = 6.022 × 1023 molecules/mol), MWDOX is the molecular weight of DOX (579.98 g/mol), and SA total is the cumulative SA per mL of the standardized MB population.
2.7. Thermodynamic Analysis of Drug Adsorption
2.7.1. Adsorption Modeling
DOX adsorption data associated with each loading descriptor were analyzed using simplified phenomenological adsorption models to characterize the apparent dependence of interfacial uptake on bulk DOX concentration and lipid shell composition. At low interfacial coverage, adsorption was described using a Henry-type adsorption regime: qe = KHCe. Where qe is the interfacial concentration, KH is the Henry-type adsorption constant, and Ce is the DOX bulk concentration. To evaluate the influence of lipid shell composition on adsorption, the dependence of DOX uptake on χDPPS was described using the linear relationship:
| 10 |
where k is the sensitivity coefficient describing the dependence of adsorption on χDPPS, and b represents baseline adsorption at χDPPS = 0.0, corresponding to adsorption on DPPC/DSPE-mPEG2000 shells in the absence of DPPS.
The nonlinear increase in DOX adsorption was analyzed using a simplified Gouy–Chapman–Boltzmann framework relating interfacial concentration (Γ, DOX encapsulated) to surface potential (ψ0): . Where Γ0 is the DOX encapsulated in absence of DPPS, z is the valency of DOX (z = +1), F is the Faraday constant (96,485 C/mol), R is the ideal gas constant (8.314 J·mol‑1·K‑1), and T is the absolute temperature (K).
Assuming that ψ0 scales linearly with χDPPS at low potentials (ψ0 – 25 mV), the model simplifies to
| 11 |
Experimental data were fitted to both linear and nonlinear regimes. The preferred model was selected based on the highest R2 value, and the corresponding k value was used to quantify the dependence of DOX adsorption on χDPPS.
2.7.2. Apparent Gibbs Free Energy of Adsorption
The apparent Gibbs free energy of adsorption (ΔGapp) was determined as a comparative descriptor of the apparent adsorption affinity of DOX toward the MB shell. ΔGapp was calculated from the dimensionless apparent adsorption coefficient (Kapp), obtained from the loading descriptors described in Section :
| 12 |
where , DOXencapsulated is the experimentally measured amount of DOX associated with the MB shell, and DOXadded is the total amount of DOX introduced during the loading. Because Kapp is derived from loading descriptors rather than from a thermodynamic adsorption equilibrium constant, ΔGapp should be interpreted as an apparent adsorption free-energy descriptor (ΔGapp, mass, ΔGapp, MB or ΔGapp, SA).
Based on previous studies describing DOX adsorption at anionic phospholipid interfaces, the intermolecular interactions considered in this framework included hydrophobic interactions with lipid hydrocarbon domains, electrostatic interactions with anionic lipid components (DPPS and DSPE-mPEG2000) , and DOX–DOX π–π self-association. The relative contributions of electrostatic, hydrophobic, and DOX–DOX π–π interactions were estimated using a hierarchical interaction framework based on the interaction range. Electrostatic interactions were assigned first because their longer interaction range is expected to govern the initial association of DOX with anionic DPPS and DSPE-mPEG2000 headgroups. Hydrophobic interactions were subsequently assigned as short-range lipid-associated interactions, followed by DOX–DOX π–π stacking, which requires close proximity between aromatic rings.
The electrostatic contribution was estimated as
| 13 |
where NDPPS and correspond to the number of available anionic lipid molecules and NDOX is the total number of adsorbed DOX molecules.
At χDPPS = 0.0, adsorbed DOX molecules exceeding the electrostatic capacity of DSPE-mPEG2000 were attributed to hydrophobic interactions:
| 14 |
where if the remaining adsorbed DOX molecules were assigned to DOX–DOX π–π interactions:
| 15 |
The number of lipid molecules (Nlipid) for each lipid species (DPPC, DPPS, or DSPE-mPEG2000) per 1 × 1010 MBs was calculated as , where χ lipid is the molar fraction of the corresponding lipid, MBSA, total is the total MB surface area normalized to 1 × 1010 MBs, and Alipid is the molecular area per lipid.
Finally, following classical approaches for describing interfacial free-energy contributions, the ΔGapp,SA was interpreted as the combined contribution of these interaction regimes:
| 16 |
where , and , where , and k is the sensitivity coefficient obtained from the fits of the linear and nonlinear adsorption models described in Section for each multiscale loading descriptor (Section ).
2.7.3. Apparent Enthalpic and Entropic Contributions
To resolve the thermodynamic drivers of adsorption, temperature-dependent adsorption experiments were performed at 277.15, 298.15, and 310.15 K. The baseline adsorption protocol described above (Section ) was independently conducted at each temperature. The temperature-dependent thermodynamic analysis was performed using the microscopic descriptor (DOXmolecules/μm2).
The temperature dependence of ΔGapp, interactions–SA was described according to
| 17 |
Apparent enthalpic (ΔHapp, SA) and entropic (ΔSapp, SA) contributions were determined from the linearized van’t Hoff equation:
| 18 |
where corresponds to the apparent adsorption coefficient calculated from the experimentally calculated SA loading descriptor at each temperature, as described in Section . Accordingly, ΔHapp,SA and ΔSapp,SA were obtained from the slope and intercept of the linear regression of ln K app, interactions–SA versus 1/T, respectively.
2.8. Analysis of Drug Loading Capacity
To determine the maximum DOX loading capacity while minimizing agglomeration, MBs exhibiting intermediate and brush PEG configurations were incubated at 298.15 K using DOX concentrations ranging from 0.5 to 2.0 mg/mL and incubation times from 10 to 60 min. Following incubation, samples were processed and characterized as described above.
2.9. Statistical Analysis
Each experimental group consisted of five independent anionic PEGylated-MB batches prepared on different days (n = 5). Data are presented as the mean ± standard deviation (SD). Statistical significance between experimental groups was evaluated using a one-way analysis of variance (ANOVA) followed by Tukey’s post-hoc test for multiple comparisons, whereas pairwise comparisons were assessed using an unpaired t-tests. Statistical analyses were generated using GraphPad Prism software (San Diego, CA, USA). A p value of p ≤ 0.05 was considered statistically significant.
3. Results and Discussion
3.1. PEG-DOX Microbubble Characterization
Anionic PEGylated MBs with controlled PEG architecturesmushroom (1 mol %), intermediate (5 mol %), and brush (10 mol %)were successfully loaded with DOX (0.5 mg/mL of DOX, 10 min incubation) yielding predominantly spherical and well-dispersed populations under most conditions (Figure A). The corresponding lipid compositions (χDPPC, χDPPS and χPEG) for each PEG architecture are summarized in Table . Additional microscopy fields corresponding to one complete quadrant of the Neubauer chamber are provided in Figure S1 to illustrate the MB populations used for quantitative analysis. DOX–MBs at χDPPS = 0.1 and 0.2 were morphologically similar to those at χDPPS = 0.0.
1.

Characterization of DOX–MBs as a function of PEG architecture and anionic lipid content. A) Representative brightfield micrographs of mushroom, intermediate and brush MBs at low (χDPPS = 0.0) and high (χDPPS = 0.4) anionic lipid content after DOX loading (0.5 mg/mL, 10 min). Fuchsia dashed outlines indicate MB aggregation. B) Number-weighted size distributions and C) corresponding surface area distributions for χDPPS = 0.2, normalized to 1 × 1010 MBs/mL. Solid lines represent Gaussian fits (R2 ≥ 0.95). (D–F) Number-weighted mean diameter (Dm), normalized SA (SAnormalized), and MB concentration yield (CMB). Data represent the mean ± standard deviation of five independent experiments. Statistical significance is indicated as *, **, ***, ****p < 0.05; $$$,$$$$p < 0.005 vs. mushroom at χDPPS = 0.2 and #, ####p < 0.05 vs. brush at χDPPS = 0.2.
At high anionic content (χDPPS = 0.4), mushroom MBs exhibited reduced colloidal stability and formed large aggregates (3–20 μm range; Figure A, and S1). The aggregate concentration (CAgg = 1.5 ± 0.6 × 1010, mean diameter (Dm= 10.2 ± 4.3 μm), and normalized SA (SAnormalized = 1.4 ± 0.6 × 1012 μm2) are shown in Figure S2. This behavior is consistent with enhanced DOX adsorption through hydrophobic and electrostatic interactions, ,, which have been reported to promote DOX–DOX π–π stacking between anthracycline moieties and cooperative inter-MB aggregation. , Although stable DOX–MBs have been reported at comparable PEG densities, , those formulations incorporated DOX during lipid assembly. In contrast, adsorption onto preformed MBs leaves DOX exposed at the lipid interface, where the low PEG grafting density provides limited steric shielding. This reduced steric protection is associated with the mushroom PEG configuration, which exhibits larger D and shorter L compared with intermediate and brush architectures (Table ), providing lower steric–diffusional hindrance. Under high χDPPS conditions, enhanced electrostatic DOX–lipid interactions and limited PEG shielding promote DOX–DOX association between neighboring MBs, leading to cooperative inter-MB aggregation within a short incubation period (Figure A). By contrast, intermediate and brush architectures remained colloidally stable under these identical conditions (10 min, 0.5 mg/mL DOX), consistent with increased PEG grafting density providing steric–diffusional hindrance ,, that limits interfacial DOX–DOX interactions and suppresses DOX–mediated MB aggregation.
2.

Schematic illustration of the proposed mechanism underlying PEG architecture-dependent, DOX-mediated cooperative inter-MB aggregation through intermolecular DOX–DOX interactions at the MB interface. (A) Mushroom and (B) intermediate PEG-coated MBs at χDPPS = 0.4 showing the DOX concentration- and incubation time-dependent aggregation behavior.
All non-aggregated formulations exhibited broad but well-defined size distributions (0.7–6.0 μm; Figure B and Figure S3) well described by Gaussian fits (R2 ≥ 0.90). Mean diameter remained nearly invariant across χDPPS (Dm = 1.40 ± 0.50 μm, Figure D), consistent with previous PEGylated MB formulations. ,,, At χDPPS = 0.4, aggregation dominated mushroom MBs, whereas brush MBs exhibited a shift toward larger individual MBs (6–10 μm, Figure S3B) without evidence of aggregation. Likewise, SAnormalized per 1.0 × 1010 MBs/mL remained ∼1.1 ± 0.5 × 1011μm2 across most formulations (Figure C). Normalization to a fixed MB concentration enabled direct comparison of size-dependent surface area distributions despite formulation-dependent differences in MB concentration. An increase was observed only at χDPPS = 0.4 for mushroom and brush MBs (2.2 ± 0.5 × 1011 and 1.3 ± 0.2 × 1011 μm2, respectively; Figure E).
MB concentration decreased monotonically with increasing χDPPS (Figure F), reaching minimum values of 9.7 ± 0.6 × 109, 1.4 ± 0.2 × 1010, and 6.4 ± 0.3 × 109 MBs/mL for mushroom, intermediate,
brush MBs, respectively. Similar MB concentrations were obtained before DOX incubation, indicating that this trend arises from increasing DPPS content rather than the adsorption process. Negatively charged phospholipids are known to alter lipid packing and interfacial organization through electrostatic repulsion between lipid headgroups, which likely reduces MB formation efficiency as χDPPS increases. Nevertheless, all formulations remained within clinically relevant concentration ranges for ultrasound contrast agents (5 × 108–1.2 × 1010 MBs/mL), supporting translational feasibility. Collectively, these results highlight the role of PEG architecture and anionic lipid composition in determining the colloidal stability and morphological properties of DOX–MBs.
3.2. Multiscale Analysis of DOX Encapsulation
DOX encapsulation was initially quantified using encapsulation efficiency (EE%) as a bulk descriptor of loading yield (Figure A). Across all PEG architectures, EE% increased monotonically with χDPPS, consistent with enhanced electrostatic interactions between DOX and the anionic lipid monolayer. Conversely, EE% decreased with increasing PEG density, indicating that densely packed PEG layers impose a steric constraints that limit bulk DOX loading. , Mushroom MBs exhibited the highest EE% at low and intermediate χDPPS (22.0 ± 1.1% and 33.0 ± 2.0%, respectively), whereas χDPPS= 0.4 was excluded due to extensive aggregation (Figure A and Figure S1). Intermediate MBs showed the largest relative increase in EE% (13.0 ± 2.2% to 38.0 ± 5.0%), whereas brush MBs reached 18.0 ± 4.0% at χDPPS= 0.4. These trends are consistent with previous studies employing low PEG densities to maximize DOX loading and acoustic response. , However, although higher PEG densities have demonstrated therapeutic efficacy, ,, their effects on interfacial adsorption and molecular loading remain poorly understood. Importantly, EE% is a bulk descriptor of loading yield and does not directly account for formulation-dependent variations in MB concentration, size distribution, and accessible interfacial area. Although the Dm remained relatively constant across formulations (Figure D), differences in MB concentration (Figure F) resulted in distinct total surface area available for DOX adsorption, preventing direct comparison of size-dependent surface area contributions unless size distributions are normalized to a common MB concentration (Figure E). Therefore, EE% alone provides limited mechanistic insight into architecture-dependent DOX loading.
3.

Multiscale quantification of DOX loading across PEG-coated MB architectures. A) Encapsulation efficiency (EE%) as a function of χDPPS and PEG architecture. Statistical significance is indicated as **, ***, ****p < 0.005; &&&&p < 0.0005 vs. intermediate at χDPPS = 0.2. B–D) Multiscale DOX loading descriptors normalized to 1 × 1010 MBs/mL: B) macroscopic (DOXmass), (C) mesoscopic (DOXmolecules/MB), and (D) microscopic (DOXmolecules/μm2). Dotted lines represent linear fits (R2 > 0.95), and solid lines represent exponential fits (R2 > 0.90). Data represent the mean ± standard deviation of five independent experiments. Statistical comparisons at equivalent χDPPS are indicated as **p < 0.05 (mushroom vs. brush), $$$$p < 0.0005 (mushroom vs. intermediate), and &, &&&&p < 0.05 (brush vs. intermediate).
To decouple bulk loading from interfacial adsorption, DOX encapsulation was quantified using three hierarchical descriptors: macroscopic (DOXmass), mesoscopic (DOXmolecules/MB), and microscopic (DOXmolecules/μm2), with all formulations normalized, to 1 × 1010 MBs/mL (Figure B–D) to enable direct comparison among formulations while accounting for concentration-dependent differences in MB populations. , At the macroscopic level (Figure B), DOXmass increased linearly with χDPPS in mushroom MBs (40.2 ± 2.0 to 77.7 ± 6.9 μg/mL), whereas intermediate and brush architectures exhibited nonlinear increases, reaching 130.5 ± 7.0 and 294.0 ± 14.7 μg/mL at χDPPS = 0.4, respectively. Similar trends were observed at the mesoscopic level (Figure C), where intermediate and brush MBs reached 1.6 ± 0.1 × 107 and 3.0 ± 0.2 × 107 DOXmolecules/MB, respectively. Together, these macroscopic and mesoscopic descriptors indicate increased association at the formulation and individual MB levels. However, despite normalization to an equivalent number of MBs, both descriptors remain influenced by formulation-dependent differences in accessible interfacial area.
In contrast, microscopic normalization revealed convergence of interfacial DOX loading across architectures, with surface densities of 1.4 ± 0.1 × 106 and 2.3 ± 0.5 × 106 DOXmolecules/μm2 despite substantial differences in EE% and bulk loading (Figure D). This convergence indicates that the larger variations observed at the macroscopic and mesoscopic levels primarily arises from differences in accessible interfacial surface area rather than proportional changes in intrinsic adsorption capacity. Thus, the microscopic descriptor (DOXmolecules/μm2) minimizes geometric contributions and enables a more direct comparison of DOX interfacial adsorption behavior among PEG architectures. Importantly, this metric can be readily calculated from EE% by normalizing the encapsulated DOX to a common number of MBs and accounting for their total surface area, providing a straightforward and adaptable complementary basis for more objective and rational formulation selection based on interfacial DOX loading.
Surface-normalized descriptors are increasingly recognized as the most physically relevant metrics in lipid-based delivery systems, because interfacial density, rather than bulk concentration, governs functional performance. , This distinction is particularly important in MB systems, where identical MB concentrations can exhibit different accessible surface areas due to variations in size distributions. Consistent with these framework, our previous study demonstrated that mesoscopic descriptors can overestimate molecular loading relative to surface-normalized metrics, whereas microscopic normalization provides a robust basis for comparing MB formulations while accounting for size- and concentration-dependent differences. , Moreover, because spatial organization of DOX within the lipid shell can directly influences acoustic behavior, interfacial organization may represent an important determinant of MB functionality beyond total drug payload. While the microscopic descriptor establishes differences in DOX surface density among the evaluated formulations, whether these differences influence US-triggered drug release, cavitation behavior, and ultimately therapeutic performance remain to be determined. Determining this relationship will clarify the functional relevance of DOX surface density in drug-loaded MBs.
3.3. Thermodynamic Analysis of DOX Adsorption
3.3.1. Apparent Free Energy of Adsorption (ΔGapp)
To further evaluate the energetics of DOX loading, ΔGapp was estimated from the Kapp values derived from the loading descriptors presented in Figure B–D (Figure S4). Because the adsorption profiles did not exhibit a classical saturation plateau, Kapp was treated as an apparent operational descriptor rather than an equilibrium adsorption constant. ΔGapp was calculated at the macroscopic (ΔGapp, mass), mesoscopic (ΔGapp, MB), and microscopic (ΔGapp, SA) levels using the same
reference MB concentration (Cref =1 × 1010 MBs/mL). The Kapp values exhibited a clear dependence on lipid composition and PEG architecture (Figure S4A). Increasing PEG density reduced Kapp at a given χDPPS, indicating decreased apparent DOX accessibility associated with increasing steric crowding, whereas increasing χDPPS increased Kapp across all architectures, consistent with enhanced interactions between DOX and the anionic DPPS sites. The maximum Kapp values were 0.16 ± 0.01, 0.25 ± 0.03, and 0.60 ± 0.03 for mushroom, intermediate, and brush architectures, respectively.
Accordingly, ΔGapp values exhibited the same architecture-and composition-dependent trends observed for Kapp (Figure S4B). The consistent variations in ΔGapp, mass, ΔGapp, MB, ΔGapp, SA indicates that PEG architecture and lipid composition modulate a common interfacial adsorption process across different loading descriptors. At low χDPPS (0.0–0.2), mushroom MBs exhibited lower ΔGapp values (6.3 ± 0.1 and 4.6 ± 0.2 kJ/mol) than intermediate (7.6 ± 0.1 and 6.1 ± 0.3 kJ/mol) and brush (7.7 ± 0.4 and 6.1 ± 0.1 kJ/mol) MBs, consistent with reduced steric constraints associated with lower PEG grafting densities. Increasing χDPPS (0.3–0.4), further decreased ΔGapp for intermediate (4.1 ± 0.2 and 3.5 ± 0.3 kJ/mol) and brush (2.8 ± 0.1 and 1.3 ± 0.1 kJ/mol) MBs. These positive ΔGapp values are consistent with Kapp < 1, whereas the progressive decrease in ΔGapp reflects increasingly favorable apparent adsorption energetics. , This behavior suggests that although dense PEG layers may initially restrict DOX accessibility, the lateral heterogeneity of lipid-coated MB interfaces, characterized by phospholipid-rich domains and polymer-rich regions, may create localized interfacial environments that promote cooperative DOX accumulation.
Although ΔGapp captures the overall energetic of DOX loading, it does not resolve the molecular interactions responsible for the observed adsorption behavior. Therefore, the relative contributions of the intermolecular interactions governing DOX adsorption were quantified to elucidate the molecular origin of ΔGapp (Figure A). Previous studies have shown that DOX adsorption at phospholipid interfaces involves hydrophobic interactions with lipid hydrocarbon chains and electrostatic interactions with anionic phospholipids and DSPE-mPEG2000, ,,, whereas DOX self-association occurs through π–π stacking interactions between anthracycline rings. At χDPPS = 0.0, the relative contribution of hydrophobic interactions decreased from 94.1 ± 1.0% to 9.6 ± 13.3% as PEG density increased from mushroom to brush architectures (Figure Aa), consistent with an increase in the contribution of negatively charged DSPE-mPEG2000 (5.9 ± 1.0% to 90.4 ± 13.3%). Upon incorporation of DPPS (χDPPS = 0.2), electrostatic interactions became the dominant contribution across all architectures, accounting for 76.3 ± 1.0% and 96.1 ± 4.3% of the total interaction profile (Figure Ab). At χDPPS = 0.3–0.4, intermediate architectures remained predominately governed by electrostatic interactions (82.0 ± 19.6% and 71.6 ± 7.5%), accompanied by an increased contribution from DOX–DOX π–π interactions (11.9 ± 14.2% and 20.1 ± 7.5%). In contrast, brush architectures exhibited increasingly balanced electrostatic (67.7 ± 5.5% and 50.0 ± 9.0) and DOX–DOX π–π contributions (28.5 ± 5.7% and 50.5 ± 8.1) (Figure Ab, c). This redistribution of intermolecular interactions is consistent with membrane model observations proposing a two-step DOX binding mechanism at anionic phospholipid interfaces, involving initial electrostatic association of the dihydroxyanthraquinone moiety at the membrane surface followed by partial hydrophobic insertion into the lipid interface. The relatively small hydrophobic contribution in intermediate and brush architectures is consistent with the low hydrophobicity of DOX together with the conformation-dependent hydrophobic shielding imposed by PEG chains, which is greatest in brush architectures, and the decreasing fraction of neutral lipids available for hydrophobic interactions as negatively charged phospholipid content increases. , Thus, once DOX is adsorbed at the MB interface, additional DOX loading can be associated with DOX–DOX π–π stacking interactions. ,,
4.

Molecular interaction contributions and apparent thermodynamic analysis of DOX adsorption onto PEG-coated MB architectures. A) Relative contributions of (a) hydrophobic, (b) electrostatic, and (c) DOX–DOX π–π interactions as a function of χDPPS and PEG density. B) Apparent free energy changes (ΔGapp) associated with the hydrophobic and combined electrostatic/DOX–DOX π–π adsorption regimes, evaluated using (a) macroscopic (ΔGapp,mass), (b) mesoscopic (ΔGapp,MB), and (c) microscopic (ΔGapp,SA) loading descriptors. ΔGapp values were calculated from Kapp obtained from the corresponding adsorption relationships in Figure . Data represent the mean ± standard deviation of five independent experiments. Statistical significance is indicated as *, ***, ****p < 0.05; //,///,////p < 0.005 vs. intermediate at χDPPS = 0.0 electrostatic + DOX–DOX π–π, $,$$$,$$$$p < 0.05 vs. intermediate at χDPPS = 0.2, ###, ####p < 0.005 vs. intermediate at χDPPS = 0.3, ++++p < 0.0005 vs. brush at χDPPS = 0.0 electrostatic + DOX–DOX π–π, |,|||,||||p < 0.05 vs. brush at χDPPS = 0.2, and &,&&,&&&,&&&&p < 0.05 vs. brush at χDPPS = 0.3.
To determine how these molecular interactions influence the thermodynamic driving force of DOX adsorption, their energetic contributions were subsequently evaluated across the loading descriptors (ΔGapp, interactions–mass, ΔGapp, interactions–MB, and ΔGapp, interactions–SA; Figure B) using classical interfacial free-energy frameworks, in which adsorption energetics are interpreted as the combined result of multiple molecular contributions associated with hydrophobic and hydrophilic molecular domains (eq ). At χDPPS = 0.0, ΔGapp, interactions–mass, ΔGapp, interactions–MB, and ΔGapp, interactions–SA were positive across all PEG architectures and increased from 6.3 ± 0.1 kJ/mol for mushroom MBs to 7.7 ± 0.4 kJ/mol brush MBs. This increase coincided with the reduced relative contribution of hydrophobic interactions at higher PEG densities, suggesting that PEG-induced steric constraints limit access to hydrocarbon lipid domains involved in DOX association. , Consequently, the overall adsorption process remained endergonic, , indicating that the favorable contribution of hydrophobic interactions was insufficient to compensate for the energetic costs associated with PEG organization and local interfacial rearrangement. Positive adsorption free-energy values have been reported for systems where adsorption is primarily influenced by hydrophobic interactions.
Increasing χDPPS (0.2–0.4), progressively shifted ΔGapp, interactions toward more negative values across all PEG architectures (Figure B). The ΔGapp, interactions–mass and ΔGapp, interactions–MB descriptors decreased from −0.30 ± 0.05 kJ/mol to −5.50 ± 0.30 kJ/mol at χDPPS =0.2, and from −4.70 ± 0.30 kJ/mol to −7.70 ± 0.90 kJ/mol at χDPPS = 0.4 as PEG architecture transitioned toward brush regimes. In contrast, ΔGapp, interactions–SA exhibited a narrower variation, decreasing from −1.90 ± 0.80 kJ/mol to −3.10 ± 0.60 kJ/mol at χDPPS = 0.2, and from −5.3 ± 0.40 kJ/mol to −9.1 ± 0.50 kJ/mol at χDPPS = 0.4. These changes coincided with the increasing contribution of electrostatic and DOX–DOX π–π interactions observed in Figure Ab–c, suggesting an increasingly exergonic adsorption process driven by stronger attractive interactions that favor interfacial DOX retention. , Consistently, Kapp, interactions > 1 were observed under these conditions (Figure S5), with values ranging from 1.9 ± 0.24, 9.4 ± 1.50, and 19.0 ± 5.2 for mushroom, intermediate, and brush architectures, respectively. Thus, consistent with the negative ΔGapp, interactions values obtained and support a favorable apparent adsorption process. Negative adsorption free-energy values have likewise been reported for DOX adsorption onto nanostructured and carbohydrate-based interfaces.
These results demonstrate that ΔGapp represents the net balance of multiple molecular interactions, whose individual contributions may be masked within the overall energetic profile. Similar free-energy decomposition approaches in molecular association systems have shown that resolving individual energetic components provides mechanistic insight beyond the overall free-energy value. , Moreover, molecular dynamics studies have demonstrated that the free-energy landscape governing DOX association with phospholipid interfaces is strongly dependent on lipid composition and membrane packing, which regulate the thermodynamic favorability of interfacial DOX binding. Consequently, resolving these contributions enabled the identification of the energetic factors underlying formulation-dependent DOX adsorption at the PEGylated lipid MB shell.
The lower variability of ΔGapp, interactions–SA indicates that expressing adsorption energetics per interfacial area reduces the influence of MB size distribution, enabling more meaningful comparisons among formulations. Therefore, ΔGapp, interactions–SA was selected as the most representative descriptor of apparent DOX adsorption energetics. Unlike EE%, which reflects the overall amount of DOX incorporated into the MB population, ΔGapp, interactions–SA provides insight into the energetic basis of DOX–MB association. The distinct trends between these descriptors demonstrate that the formulation exhibiting the highest DOX loading does not necessarily correspond to the one with the most favorable adsorption energetics, highlighting that the overall DOX incorporation depends on the combined effects of interfacial affinity, PEG/lipid organization, and available surface area.
3.3.2. Apparent Enthalpic (ΔHapp, SA) and Entropic (ΔSapp, SA) Contributions
The interaction-based analysis presented above provided mechanistic insight into the molecular factors governing DOX adsorption at the MB interface; however, it does not resolve the overall thermodynamic driving forces associated with the apparent adsorption process. Therefore, temperature-dependent experiments were performed across PEG architectures and χDPPS conditions under identical loading conditions (0.5 mg/mL DOX and 10 min incubation) to determine ΔH app, SA and ΔS app, SA contributions governing DOX adsorption. The evaluated temperatures (277.15, 298.15, and 310.15 K) represent relevant storage, handling, and physiological conditions for DOX–MBs.
Temperature-dependent variations in DOX–MB concentration were observed, with differences dependent on PEG architecture and lipid composition (Figure S6). Relative to 298.15 K, DOX–MB concentrations decreased at 277.15 and 310.15 K by approximately 53 ± 13%, 59 ± 5% and 56 ± 10% for mushroom, intermediate, and brush architectures, respectively, with the magnitude of these changes varying with χDPPS. These results suggest that temperature influences MB retention, likely through changes in lipid monolayer organization and interfacial rearrangements. , Additionally, these variations highlight the importance of normalizing adsorption process measurements using a common reference concentration (1 × 1010 MBs/mL), , enabling direct comparisons of interfacial adsorption behavior across temperatures, PEG architectures, and lipid compositions.
Accordingly, DOX adsorption was quantified using the microscopic descriptor (DOXmolecules/μm2). Surface loading exhibited architecture-, composition-, and temperature-dependent profiles (Figure S7A). Intermediate and brush MBs displayed nonlinear increases in surface loading with increasing χDPPS, reaching maximum values of 1.4–2.5 × 106 and 2.4–5.5 DOXmolecules/μm2, respectively. In contrast, mushroom MBs exhibited predominantly linear adsorption profiles at 277.15 and 310.15 K, whereas a nonlinear response was observed at 298.15 K, reaching lower surface densities (1.5 ± 0.2, 2.6 ± 0.2 and 0.7 ± 0.1 × 106 DOXmolecules/μm2). These adsorption profiles were subsequently used to determine Kapp, interactions–SA values for thermodynamic analysis.
Increasing temperature reduced Kapp, interactions–SA values across formulations, whereas increasing χDPPS and PEG grafting density increased Kapp, interactions–SA at each evaluated temperature (Figure S7B). Kapp, interactions–SA < 1 was generally observed at χDPPS= 0.0–0.2, whereas Kapp,interactions–SA > 1 was predominantly observed for brush MBs at χDPPS= 0.3–0.4. Although 277.15 and 310.15 K increased apparent DOX surface loading, the associated decrease in MB concentration indicates a trade-off between adsorption efficiency and MB retention (Figure S6). Therefore, 298.15 K provided the most favorable balance between DOX adsorption and MB concentration under the evaluated conditions. The dependence of Kapp, interactions–SA on PEG architecture and lipid composition indicates that adsorption affinity is governed not only by the availability of lipid binding sites but also by the physicochemical properties of the interface. Previous studies have shown that interfacial hydration can modulate drug–lipid association by altering the energetic balance of adsorption. Accordingly, the higher K app, interactions–SA values observed for PEG-dense architectures at higher χDPPS may result from a more favorable interfacial environment that promotes DOX association through electrostatic interactions and DOX–DOX π–π stacking.
To further characterize the thermodynamic basis of this temperature-dependent adsorption behavior, a van’t Hoff analysis of ln(Kapp, interactions–SA) as a function of 1/T was performed (Figure Aa). Distinct PEG architecture-dependent profiles were observed. Mushroom MBs exhibited biphasic response, with a positive slope between 277.15 and 298.15 (R2 = 1.0), and a negative slope between 298.15 and 310.15 K (R2 = 1.0). No statistically significant changes were observed between 277.15 and 298.15 K, whereas a significant decrease was observed between 298.15 and 310.15 K. Intermediate MBs exhibited minimal temperature dependence across the evaluated range (R2 = 0.97), whereas brush MBs displayed the greatest temperature sensitivity, primarily between the lowest and highest temperatures evaluated (R2 = 0.98). The biphasic response observed for mushroom MBs suggests that sparsely grafted PEG layers exhibit a distinct temperature response compared with higher grafting densities. This behavior may be associated with greater conformational adaptability of PEG chains at low grafting densities. PEG/PEO chains exhibit temperature-dependent conformational behavior in aqueous media, influenced by the balance between polymer hydration and chain organization. , Therefore, differences in PEG grafting density may regulate the extent of temperature-induced interfacial changes, resulting in distinct adsorption regimes.
5.

Temperature-dependent thermodynamic analysis of DOX adsorption at PEGylated MB interfaces. A) Temperature-dependent thermodynamic parameters obtained from the adsorption analysis: (a) Van’t Hoff plots of ln (Kapp, interactions–SA) versus 1/T. Dotted lines represent linear fits with (R2 > 0.98). Statistical significance is indicated as ****p < 0.0005, and &&p < 0.005 (mushroom vs. brush). Corresponding (b) apparent enthalpic (ΔHapp, SA) and (c) entropic (ΔSapp, SA) contributions. Mushroom 1 (298.15 to 310.15 K) and Mushroom 2 (277.15–298.15 K). Statistical significance is indicated as *, **, ***, ****p < 0.05; |p < 0.05 vs. brush at χDPPS = 0.2, and &p < 0.05 vs. brush at χDPPS = 0.3. B) Apparent adsorption free energy (ΔGapp,interactions–SA) calculated from the enthalpic and entropic contributions (ΔGapp,interactions–SA= ΔHapp, SA–TΔSapp, SA) at (a) 277.15 K, (b) 298.15 K, and (c) 310.15 K. Statistical significance is indicated as *, **, ***, ****p < 0.05; |p < 0.05 vs. brush at χDPPS = 0.2, and &p < 0.05 vs. brush at χDPPS = 0.3. Data represent the mean ± standard deviation of five independent experiments.
The ΔHapp, SA and ΔS app, SA values were subsequently derived from the slope (m = −ΔHapp,SA/R) and intercept (b = ΔSapp,SA/R) of the van’t Hoff plots, respectively. According to the van’t Hoff relationship, positive slopes correspond to exothermic (ΔHapp, SA < 0) processes, whereas negative slopes indicate endothermic processes (ΔHapp, SA > 0). , Positive ΔHapp, SA values were observed for all PEG architectures at χDPPS = 0.0–0.3 and progressively decreased with increasing χDPPS (Figure Ab). Specifically, ΔHapp,SA increased from 4.3 ± 2.4 kJ/mol to 10.8 ± 3.4 kJ/mol for mushroom MBs (Mushroom 1, 298.15 to 310.15 K) and decreased from 19.3 ± 1.8 kJ/mol to 14.5 ± 1.9 kJ/mol for intermediate MBs, and from 33.8 ± 3.6 kJ/mol to −20.5 ± 3.7 kJ/mol for brush MBs. At χDPPS = 0.4, ΔH app, SA was positive for intermediate (13.1 ± 2.4 kJ/mol) and became negative for brush MBs (−27.8 ± 4.1 kJ/mol). For mushroom MBs, the 277.15–298.15 K regime (Mushroom 2) yielded a negative ΔH app, SA value (−6.5 ± 3.47 kJ/mol).
Overall, ΔS app, SA values were small in magnitude across all conditions (on the order of 10–2 kJ/mol) (Figure Ac). Nevertheless, architecture- and composition-dependent sign changes were observed. Mushroom MBs exhibited predominantly negative ΔS app, SA values, whereas intermediate and brush MBs displayed positive values at low χDPPS that shifted toward negative values with increasing χDPPS. Increasing PEG grafting density above χPEG = 0.05 has been reported to promote lipid headgroup dehydration, enhanced lateral packing of lipid acyl chains, and hydration of the outer PEG layer, reducing interfacial defects and increasing PEGylated interface stability. These structural rearrangements impose conformational constraints within the PEG layer, contributing to the unfavorable ΔS app, SA observed during adsorption. The favorable ΔS app, SA contributions observed for intermediate and brush architectures at χDPPS = 0.4 may therefore reflect stabilizing DOX–interface interactions that compensate for ΔS app, SA penalty associated with PEG-mediated organization.
The combined ΔHapp, SA and ΔS app, SA contributions were subsequently used to calculate ΔGapp, interactions– SA according to eq (Figure B). Across all temperatures, ΔGapp, interactions– SA decreased with increasing χDPPS from 0.0 to 0.3 for all PEG architectures. At χDPPS = 0.4, intermediate MBs exhibited the lowest ΔGapp, interactions– SA values at 277.15 and 298.15 K (1.45 ± 0.7 kJ/mol and 1.01 ± 0.2 kJ/mol, respectively), whereas brush MBs displayed negative ΔGapp, interactions– SA under these conditions (−3.1 ± 2.4 kJ/mol and −1.3 ± 0.9 kJ/mol, respectively). The magnitude of ΔGapp, interactions– SA was consistent with the trends observed for K app, interactions–SA and with the net apparent free-energy contributions associated with the different adsorption interaction regimes (Figure , eq ), supporting the thermodynamic framework proposed for DOX adsorption at the MB interface. The favorable ΔGapp, interactions– SA values obtained at 298.15 K, combined with the higher MB concentration retained at this temperature, supported its selection for DOX–MB formulation.
3.4. Thermodynamically Guided Optimization of Interfacial Loading
Guided by the thermodynamic framework, DOX loading was optimized by varying incubation time and drug concentration in intermediate and brush architectures at χDPPS = 0.0 and 0.4 (Figure ). Mushroom MBs were excluded because of instability under highly charged and prolonged incubation conditions (>10 min at χDPPS = 0.2), limiting their suitability for high-payload formulations.
6.

Maximization of interfacial DOX loading under extended incubation and concentration conditions. (A) Intermediate and (B) brush architectures evaluated at χDPPS = 0.0 and 0.4. (a) Number-weighted size distributions; shaded regions denote standard deviation (SD). Solid lines represent Gaussian fits (R2 ≥ 0.95), and dashed lines indicate point-to-point connections. (b) Total microbubble concentration (CMB) and (c) interfacial loading expressed as DOXmolecules/μm2, normalized to 1 × 1010 MBs/mL. Statistical significance is indicated as *p < 0.05. Data represent the mean ± standard deviation of five independent experiments.
Number-weighted size distributions (Figure Aa) exhibited-well-defined populations across all evaluated conditions and were described by Gaussian fits (R2 ≥ 0.95). In the brush architectures, incorporation of DPPS shifted MB populations toward smaller diameters relative to χDPPS = 0.0, resulting in Dm of ∼1.7 ± 0.8 μm (Figure S8Ab) and SA normalized to 1 × 1010 MBs/mL of ∼1.1 ± 0.2 × 1011μm2 (Figure S8Ac). Correspondingly, CMB (Figure Ab–Bb) decreased in the presence of DPPS, consistent with increased interfacial electrostatic stress in highly anionic formulations. At χDPPS = 0.0, CMB reached 2.5 ± 0.5 × 1010 MBs/mL, whereas χDPPS = 0.4 reduced concentrations to 1.2 ± 0.3 × 1010 MBs/mL for intermediate MBs and 2.3 ± 0.8 × 109 MBs/mL for brush MBs. However, when normalized to 1 × 1010 MBs/mL, the accessible SA increased to ∼1.5 ± 0.5 × 1011μm2 (Figure S8Bc).
Interfacial loading (Figure A) revealed distinct architecture-dependent optimization windows. In intermediate MBs, loading remained comparable between 10- and 20 min incubation (∼1.3 ± 0.2 × 106 DOXmolecules/μm2) using 0.5 mg/mL DOX, increasing to 1.6 ± 0.04 × 106 DOXmolecules/μm2 at 30 min. However, extending incubation beyond 30 min or increasing DOX concentration to 1.0 mg/mL induced MB agglomeration (Figure S9), indicating that loading capacity was constrained by limited colloidal stability under elevated interfacial stress. This behavior can be explained by the larger PEG chain dimensions and increased chain extension relative to mushroom MBs (Table ), which provide greater steric accommodation for DOX within the PEG layer. Therefore, higher interfacial DOX densities are required before adsorbed DOX molecules become sufficiently exposed to promote DOX–DOX π–π association between neighboring MBs. As a result, aggregation is progressively favored with prolonged incubation or increased DOX concentration as the interfacial DOX accumulation increases (Figure B).
In contrast, brush architectures remained colloidally stable across all evaluated conditions (Figure S10) and exhibited substantial increases in interfacial loading with increasing DOX concentration, raising from 3.1 ± 0.8 × 106 at 1.0 mg/mL to 6.2 ± 1.5 × 106 at 2.0 mg/mL without evidence of aggregation. This behavior is consistent with the greater PEG chain length and grafting density of the brush architecture, which provide a larger interfacial volume for DOX incorporation and prevent the critical interfacial DOX density required for intermolecular DOX–DOX π–π stacking between neighboring MBs from being reached under the evaluated conditions.
Although MB concentration decreased with increasing χDPPS, DOXmolecules/μm2 increased because this parameter was calculated after normalizing MB concentration to 1 × 1010 MBs/mL. At this equivalent MB population, the accessible surface area showed a slight increase with χDPPS, while the amount of adsorbed DOX increased to a greater extent, resulting in higher DOX surface density. This indicates that the enhanced loading arises from stronger DOX–MB interfacial interactions rather than from differences in MB concentration.
These findings support the thermodynamic framework, demonstrating that architectures exhibiting more favorable ΔGapp, interactions–SA and ΔHapp,SA values not only support higher interfacial loading but also provide expanded colloidal stability window for high-payload formulations. All together, these results demonstrate that optimization of DOX–MB formulations are governed by the underlying interfacial energetics that regulate both adsorption capacity and colloidal stability, rather than by empirical loading conditions alone.
3.5. Comparison of Interfacial Loading and Interaction Contributions across PEG Architectures
Integration of the optimal architecture-specific conditions revealed a hierarchical increase in maximal interfacial DOX loading across PEG conformations (Figure A). Mushroom MBs exhibited the lowest surface density, reaching 8.0 ± 0.7 × 105 DOXmolecules/μm2 (77.7 ± 6.9 μg/mL at χDPPS = 0.2, 0.5 mg/mL DOX, 10 min), followed by intermediate MBs with 1.6 ± 0.04 × 106 DOXmolecules/μm2 (182.6 ± 9.9 μg/mL; χDPPS =0.4, 0.5 mg/mL DOX, 30 min). In contrast, brush architectures produced an increase in loading, reaching 6.2 ± 1.5 × 106 DOXmolecules/μm2 (1017.3 ± 77.7 μg/mL; χDPPS =0.4, 2.0 mg/mL DOX, 60 min). These findings demonstrate that PEG organization is not merely a steric modifier but as a dominant regulator of interfacial drug adsorption capacity. The increased loading was accompanied by a progressive shift in the dominant interaction mechanisms governing adsorption (Figure B). In mushroom MBs, adsorption was primarily driven by hydrophobic interactions (56.0 ± 4.9%), with secondary electrostatic contributions (41.7 ± 3.4%). Transition to the intermediate regime shifted the interaction landscape toward electrostatic dominance (77.1 ± 20.9%) together with the emergence of π–π interactions (15.3 ± 14.2%). In contrast, brush architectures exhibited adsorption predominantly governed by π–π interactions (78.9 ± 5.12%), whereas electrostatic (19.0 ± 2.4%) and hydrophobic contributions (2.9 ± 0.2%) became comparatively minor.
7.

Architecture-dependent DOX loading and interaction contributions. (A) Maximum interfacial DOX loading for mushroom, intermediate, and brush PEGylated MBs, expressed as DOXmolecules/μm2 and normalized to 1 × 1010 MBs/mL, under optimal conditions: mushroom (χDPPS = 0.2, 0.5 mg/mL DOX, 10 min), intermediate (χDPPS = 0.4, 0.5 mg/mL DOX, 30 min), and brush (χDPPS = 0.4, 2.0 mg/mL DOX, 60 min). (B) Relative contribution (%) of hydrophobic, electrostatic, and DOX–DOX π–π interactions to DOX adsorption across PEG architectures. Statistical significance is indicated as ****p < 0.0005; ####p < 0.0005 vs. mushroom (hydrophobic); ///p < 0.0005 vs. intermediate (hydrophobic); and ++++p < 0.0005 vs. brush (hydrophobic), and &&&&p < 0.0005 vs. brush (electrostatic). Data represent the mean ± standard deviation of five independent experiments.
Although the relative contributions of hydrophobic, electrostatic, and π-related interactions are inherently system-dependent, molecular simulations of lipid interfaces have shown that adsorption is governed by a coupled free-energy landscape in which interfacial hydration structure plays a central role in modulating the balance of these interactions. Here, we extend this framework by demonstrating that PEG architecture strongly regulates both interfacial accessibility and the hierarchy of interactions driving DOX adsorption. Although the dense PEG layer in the brush architecture limits DOX diffusion toward the lipid interface through excluded-volume effects, this restriction is overcome as χDPPS increases. In the absence of negatively charged lipids, reduced hydrophobic interactions indicate limited DOX access to the phospholipid monolayer. However, higher χDPPS promotes electrostatic attraction and DOX–DOX π–π interactions, which dominate interfacial accumulation. Thus, despite PEG-mediated steric constraints, favorable electrostatic interactions and time-dependent DOX diffusion enable enhanced loading at the brush interface.
Because DOX loading is mediated through non-covalent interactions, interfacial retention remains inherently reversible and susceptible to leakage. , Consequently, interaction strength becomes a critical determinant of payload stability. In mushroom MBs, hydrophobic-dominated adsorption was associated with less favorable ΔGapp, SA values, indicating weaker interfacial stabilization and limited retention capacity, thereby challenging the use of low PEG density MBs for maximizing DOX loading. , In contrast, intermediate and brush architectures exhibited progressively more favorable ΔGapp, SA together with enhanced loading, consistent with stronger intermolecular stabilization and improved retention, ,, thus supporting their use in therapeutic applications. Notably, π–π interactions have been reported to stabilize DOX-loaded nanosystems by preserving structural integrity upon dilution, improving circulation bioavailability, and enhancing tumor accumulation. Accordingly, brush architectures combined with the most favorable ΔGapp, SA values, highest loading capacity, and dominant π–π interactions, emerges as the most effective configuration for maximizing interfacial drug retention.
Importantly, previously reported DOX payloads for intermediate and brush MB systems typically range from ∼350–750 μg, , whereas optimized mushroom-based formulations can reach ∼1400–2500 μg. , However, these increases are frequently achieved using formulation-dependent strategies involving organic solvents or elevated temperatures, which may compromise drug integrity and limit clinical translatability. In contrast, the payloads achieved here were obtained using medical-grade DOX under mild aqueous conditions and supported by a thermodynamic framework that directly linking PEG architecture to adsorption energetics, enabling rational selection of optimal interfacial configurations rather than empirical optimization of the formulation. These findings also reconcile previously divergent observations regarding PEG density in MB systems. Low PEG-density mushroom regimes have been associated with prolonged circulation and improved performance in neutral MBs, favoring diagnostic applications. In contrast, higher PEG densities mitigate complement activation in anionic MBs and, as demonstrated here, enhance interfacial adsorption strength and loading stability. Rather than representing contradictory behaviors, these effects reflect distinct functional requirements. Overall, PEG architecture emerges as an application-specific design parameter that distinguishes imaging-optimized from therapy-optimized MB formulation, providing a framework to investigate how interfacial properties translate into US-triggered drug release, cavitation, and ultimately therapeutic performance.
4. Conclusion
In conclusion, optimization of drug-loaded MB formulations has traditionally relied on bulk metrics such as encapsulation efficiency, assuming that greater drug incorporation reflects improved performance. Here, we demonstrate that bulk loading does not necessarily represent the interfacial adsorption behavior governing drug incorporation. By combining MB concentration normalization with multiscale loading analysis, DOXmolecules/μm2 was identified as the most physically relevant descriptor because it directly relates drug loading to the available interfacial area while reducing variability associated with MB concentration, size, and population distribution. Importantly, DOXmolecules/μm2 provides a readily adaptable, complementary metric to conventional bulk parameters such as EE%, enabling a more objective basis for formulation selection based on interfacial DOX loading. Using this framework, PEG architecture and grafting density were shown to modulate apparent adsorption energetics, revealing that formulations with more favorable interfacial interactions do not always correspond to those with the highest EE%. These findings establish a mechanism-based approach for evaluating and optimizing therapeutic MB formulations according to their interfacial adsorption properties rather than empirical bulk loading alone, providing a rational foundation for the development of next-generation MB-based drug delivery platforms. Linking these interfacial properties to US-mediated drug release and cavitation will be an important next step toward establishing how the molecular basis of DOX incorporation translates into the functional performance of drug-loaded MBs.
Supplementary Material
Acknowledgments
The authors gratefully acknowledge Dr. Bruno Alfonso Escalante Acosta for providing the infrastructure, reagents, and materials essential to this study. We also thank Dr. Jesús Santana Solano and Dr. Gabriel Arturo Caballero Robledo for access to microscopy and imaging facilities. All are affiliated with Cinvestav-Monterrey, whose support was instrumental to the completion of this work. Jose Angel Navarro-Becerra acknowledges financial support from SECITHI through a postdoctoral scholarship.
Glossary
Abbreviation
- PEG
polyethylene glycol
- MBs
microbubbles
- US
ultrasound
- DOX
doxorubicin
- DPPC
dipalmitoyl-sn-glycero-3-phosphocholine
- DPPS
1,2-dipalmitoyl-sn-glycero-3-phospho-l-serine
- DSPE-mPEG2000
1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000]
- PBS
phosphate-buffered saline
- SD
standard deviation
- SA
surface area
- EE%
encapsulation efficiency.
The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acs.langmuir.6c03030.
Figure S1: representative optical microscopy images corresponding to one complete counting quadrant of the Neubauer chamber for DOX–MBs containing different DPPS fractions (χDPPS = 0.0, 0.2, and 0.4) and exhibiting mushroom, intermediate, and brush PEG architectures; Figure S2: characterization of agglomerates formed in DOX–MBs exhibiting the mushroom PEG regime at high χDPPS; Figure S3: size and surface area distributions of DOX–MBs with different PEG architectures and χDPPS; Figure S4: multiscale apparent adsorption constants and apparent Gibbs free energies of adsorption for DOX–MBs; Figure S5: temperature-dependent thermodynamic analysis of DOX adsorption contributions; Figure S6: temperature-dependent variations in DOX–MB concentration across PEG architectures; Figure S7: Microscopic DOX loading and apparent adsorption constants (Kapp, interactions–SA) as a function of χDPPS for mushroom, intermediate and brush PEG architectures at (a) 277.15 K, (b) 298.15 K, and (c) 310.15 K; Figure S8: characterization of intermediate and brush DOX–MB as a function of DOX concentration and incubation time; Figure S9: characterization of DOX–MB agglomerate formation in the intermediate PEG architecture at χDPPS = 0.4; Figure S10: representative neubauer chamber reconstructions of DOX-MBs in the brush PEG architecture at χDPPS = 0.4 (PDF)
L.E.C.M. performed the experiments, analyzed the data, and contributed to manuscript review and editing. A.R. contributed to data analysis and manuscript review and editing. J.A.N.B. conceptualized and designed the study, supervised the research, analyzed the data, and wrote and approved the manuscript. All authors have read and agreed to the published version of the manuscript.
The authors declare no competing financial interest.
References
- Navarro-Becerra J. A., Borden M. A.. Targeted Microbubbles for Drug, Gene, and Cell Delivery in Therapy and Immunotherapy. Pharmaceutics. 2023;15(6):1625. doi: 10.3390/pharmaceutics15061625. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Barmin R. A., Moosavifar M., Herrmann A., Kiessling F., Lammers T., Pallares R. M.. Multifunctional Ultrasound Microbubbles. Chem. Rev. 2026;126:1949–2005. doi: 10.1021/acs.chemrev.5c00280. [DOI] [PubMed] [Google Scholar]
- Schoen S., Kilinc M. S., Lee H., Guo Y., Degertekin F. L., Woodworth G. F., Arvanitis C.. Towards Controlled Drug Delivery in Brain Tumors with Microbubble-Enhanced Focused Ultrasound. Adv. Drug Delivery Rev. 2022;180:114043. doi: 10.1016/j.addr.2021.114043. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Navarro-Becerra J. A., Castillo J. I., Di Ruzza F., Borden M. A.. Monodispersity Increases Adhesion Efficiency and Specificity for Ultrasound-Targeted Microbubbles. ACS Biomater. Sci. Eng. 2023;9(2):991–1001. doi: 10.1021/acsbiomaterials.2c00528. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Castillo J. I., Navarro-Becerra J. A., Angelini I., Kokoshinskiy M., Borden M. A.. Frequency-Selective Microbubble Targeting In Vitro: A Step Toward Multicolor Ultrasound Molecular Imaging. ACS Appl. Bio Mater. 2025;8(3):2128–2140. doi: 10.1021/acsabm.4c01699. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Navarro-Becerra J. A., Franco-Urquijo C. A., Ríos A., Escalante B.. Localized Delivery of Caveolin-1 Peptide Assisted by Ultrasound-Mediated Microbubble Destruction Potentiates the Inhibition of Nitric Oxide-Dependent Vasodilation Response. Ultrasound Med. Biol. 2021;47(6):1559–1572. doi: 10.1016/j.ultrasmedbio.2021.02.003. [DOI] [PubMed] [Google Scholar]
- Villa-Martínez E., Rios A., Gutiérrez-Vidal R., Escalante B.. Potentiation of Anti-Angiogenic eNOS-siRNA Transfection by Ultrasound-Mediated Microbubble Destruction in Ex Vivo Rat Aortic Rings. PLoS One. 2024;19(8):e0308075. doi: 10.1371/journal.pone.0308075. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Franco-Urquijo C. A., Navarro-Becerra J., Ríos A., Escalante B.. Release of Vascular Agonists from Liposome-Microbubble Conjugate by Ultrasound-Mediated Microbubble Destruction: Effect on Vascular Function. Drug Delivery Transl. Res. 2022;12(5):1175–1186. doi: 10.1007/s13346-021-00994-7. [DOI] [PubMed] [Google Scholar]
- Corro R., Urquijo C. F., Aguila O., Villa E., Santana J., Rios A., Escalante B.. Use of Nitric Oxide Donor-Loaded Microbubble Destruction by Ultrasound in Thrombus Treatment. Molecules. 2022;27(21):7218. doi: 10.3390/molecules27217218. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ting C.-Y., Fan C.-H., Liu H.-L., Huang C.-Y., Hsieh H.-Y., Yen T.-C., Wei K.-C., Yeh C.-K.. Concurrent Blood–Brain Barrier Opening and Local Drug Delivery Using Drug-Carrying Microbubbles and Focused Ultrasound for Brain Glioma Treatment. Biomaterials. 2012;33(2):704–712. doi: 10.1016/j.biomaterials.2011.09.096. [DOI] [PubMed] [Google Scholar]
- Chuang C.-F., Lin C.-W., Yeh C.-K.. Ultrasound-Triggered Drug Release and Cytotoxicity of Microbubbles with Diverse Drug Attributes. Ultrason. Sonochem. 2025;112:107182. doi: 10.1016/j.ultsonch.2024.107182. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lin C.-W., Fan C.-H., Yeh C.-K.. The Relationship between Surface Drug Distribution of Dox-Loaded Microbubbles and Drug Release/Cavitation Behaviors with Ultrasound. Ultrason. Sonochem. 2024;102:106728. doi: 10.1016/j.ultsonch.2023.106728. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Garbett N. C., Chaires J. B.. Thermodynamic Studies for Drug Design and Screening. Expert Opin. Drug Discovery. 2012;7(4):299–314. doi: 10.1517/17460441.2012.666235. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Klebe G.. Applying Thermodynamic Profiling in Lead Finding and Optimization. Nat. Rev. Drug Discovery. 2015;14(2):95–110. doi: 10.1038/nrd4486. [DOI] [PubMed] [Google Scholar]
- Singh D., Krishna V., Kumari N., Banerjee A., Kapoor P.. Thermodynamics of Polymer Drug Interactions: An Influential Factor for the Development of a Stable Drug Delivery System. J. Macromol. Sci., Part B: phys. 2026;65(2):303–313. doi: 10.1080/00222348.2024.2419773. [DOI] [Google Scholar]
- Dong E., Huo Q., Zhang J., Han H., Cai T., Liu D.. Advancements in Nanoscale Delivery Systems: Optimizing Intermolecular Interactions for Superior Drug Encapsulation and Precision Release. Drug Delivery Transl. Res. 2025;15(1):7–25. doi: 10.1007/s13346-024-01579-w. [DOI] [PubMed] [Google Scholar]
- Tinkov S., Winter G., Coester C., Bekeredjian R.. New Doxorubicin-Loaded Phospholipid Microbubbles for Targeted Tumor Therapy: Part I – Formulation Development and in-Vitro Characterization. J. Controlled Release. 2010;143(1):143–150. doi: 10.1016/j.jconrel.2009.12.026. [DOI] [PubMed] [Google Scholar]
- Lin C.-W., Fan C.-H., Yeh C.-K.. The Impact of Surface Drug Distribution on the Acoustic Behavior of DOX-Loaded Microbubbles. Pharmaceutics. 2021;13(12):2080. doi: 10.3390/pharmaceutics13122080. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tinkov S., Coester C., Serba S., Geis N. A., Katus H. A., Winter G., Bekeredjian R.. New Doxorubicin-Loaded Phospholipid Microbubbles for Targeted Tumor Therapy: In-Vivo Characterization. J. Controlled Release. 2010;148(3):368–372. doi: 10.1016/j.jconrel.2010.09.004. [DOI] [PubMed] [Google Scholar]
- Ceballos J. A., Jaramillo-Isaza S., Calderón J. C., Miranda P. B., Giraldo M. A.. Doxorubicin Interaction with Lipid Monolayers Leads to Decreased Membrane Stiffness When Experiencing Compression–Expansion Dynamics. Langmuir. 2023;39(25):8603–8611. doi: 10.1021/acs.langmuir.3c00250. [DOI] [PubMed] [Google Scholar]
- Abou-Saleh R. H., Swain M., Evans S. D., Thomson N. H.. Poly(Ethylene Glycol) Lipid-Shelled Microbubbles: Abundance, Stability, and Mechanical Properties. Langmuir. 2014;30(19):5557–5563. doi: 10.1021/la404804u. [DOI] [PubMed] [Google Scholar]
- Navarro-Becerra J. A., Castillo J. I., Borden M. A.. Effect of Poly(Ethylene Glycol) Configuration on Microbubble Pharmacokinetics. ACS Biomater. Sci. Eng. 2024;10(5):3331–3342. doi: 10.1021/acsbiomaterials.3c01764. [DOI] [PMC free article] [PubMed] [Google Scholar]
- De Gennes P. G.. Polymers at an Interface; a Simplified View. Adv. Colloid Interface Sci. 1987;27(3–4):189–209. doi: 10.1016/0001-8686(87)85003-0. [DOI] [Google Scholar]
- Dicker S., Mleczko M., Siepmann M., Wallace N., Sunny Y., Bawiec C. R., Schmitz G., Lewin P., Wrenn S. P.. Influence of Shell Composition on the Resonance Frequency of Microbubble Contrast Agents. Ultrasound Med. Biol. 2013;39(7):1292–1302. doi: 10.1016/j.ultrasmedbio.2013.02.462. [DOI] [PubMed] [Google Scholar]
- Azami R. H., Aliabouzar M., Osborn J., Kumar K. N., Forsberg F., Eisenbrey J. R., Mallik S., Sarkar K.. Material Properties, Dissolution and Time Evolution of PEGylated Lipid-Shelled Microbubbles: Effects of the Polyethylene Glycol Hydrophilic Chain Configurations. Ultrasound Med. Biol. 2022;48(9):1720–1732. doi: 10.1016/j.ultrasmedbio.2022.04.216. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zhang H., Lu C., Yu A. C. H., Qin P.. Characterization of Stability and Shell Elasticity of Monodisperse Microbubbles with Different Pegylated-Lipid Content Using Pressure-Dependent Attenuation Spectra. Acta Biomater. 2025;204:596–609. doi: 10.1016/j.actbio.2025.08.017. [DOI] [PubMed] [Google Scholar]
- Segers T., Lohse D., Versluis M., Frinking P.. Universal Equations for the Coalescence Probability and Long-Term Size Stability of Phospholipid-Coated Monodisperse Microbubbles Formed by Flow Focusing. Langmuir. 2017;33(39):10329–10339. doi: 10.1021/acs.langmuir.7b02547. [DOI] [PubMed] [Google Scholar]
- Fisher N. G., Christiansen J. P., Klibanov A., Taylor R. P., Kaul S., Lindner J. R.. Influence of Microbubble Surface Charge on Capillary Transit and Myocardial Contrast Enhancement. J. Am. Coll Cardiol. 2002;40(4):811–819. doi: 10.1016/S0735-1097(02)02038-7. [DOI] [PubMed] [Google Scholar]
- Chen C. C., Sirsi S. R., Homma S., Borden M. A.. Effect of Surface Architecture on In Vivo Ultrasound Contrast Persistence of Targeted Size-Selected Microbubbles. Ultrasound Med. Biol. 2012;38(3):492–503. doi: 10.1016/j.ultrasmedbio.2011.12.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fix S. M., Nyankima A. G., McSweeney M. D., Tsuruta J. K., Lai S. K., Dayton P. A.. Accelerated Clearance of Ultrasound Contrast Agents Containing Polyethylene Glycol Is Associated with the Generation of Anti-Polyethylene Glycol Antibodies. Ultrasound Med. Biol. 2018;44(6):1266–1280. doi: 10.1016/j.ultrasmedbio.2018.02.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Borden M. A., Martinez G. V., Ricker J., Tsvetkova N., Longo M., Gillies R. J., Dayton P. A., Ferrara K. W.. Lateral Phase Separation in Lipid-Coated Microbubbles. Langmuir. 2006;22(9):4291–4297. doi: 10.1021/la052841v. [DOI] [PubMed] [Google Scholar]
- Borden M. A.. Intermolecular Forces Model for Lipid Microbubble Shells. Langmuir. 2019;35(31):10042–10051. doi: 10.1021/acs.langmuir.8b03641. [DOI] [PubMed] [Google Scholar]
- Demel R. A., Paltauf F., Hauser H.. Monolayer Characteristics and Thermal Behavior of Natural and Synthetic Phosphatidylserines. Biochemistry. 1987;26(26):8659–8665. doi: 10.1021/bi00400a025. [DOI] [PubMed] [Google Scholar]
- Qin S.-S., Yu Z.-W., Yu Y.-X.. Structural Characterization on the Gel to Liquid-Crystal Phase Transition of Fully Hydrated DSPC and DSPE Bilayers. J. Phys. Chem. B. 2009;113(23):8114–8123. doi: 10.1021/jp808779r. [DOI] [PubMed] [Google Scholar]
- Navarro-Becerra J. A., Caballero-Robledo G. A., Franco-Urquijo C. A., Ríos A., Escalante B.. Functional Activity and Endothelial-Lining Integrity of Ex Vivo Arteries Exposed to Ultrasound-Mediated Microbubble Destruction. Ultrasound Med. Biol. 2020;46(9):2335–2348. doi: 10.1016/j.ultrasmedbio.2020.05.004. [DOI] [PubMed] [Google Scholar]
- Navarro-Becerra J. A., Song K.-H., Martinez P., Borden M. A.. Microbubble Size and Dose Effects on Pharmacokinetics. ACS Biomater. Sci. Eng. 2022;8(4):1686–1695. doi: 10.1021/acsbiomaterials.2c00043. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Danat B. T., Wuana R. A., Chahul H. F., Iorungwa M. S.. Review of Adsorption Isotherms Models. Appl. Water Sci. 2026;16(3):72. doi: 10.1007/s13201-025-02682-0. [DOI] [Google Scholar]
- Israelachvili, J. N. Intermolecular and Surface Forces, 3rd ed.; Academic Press: Burlington, MA, 2011. [Google Scholar]
- Frézard F., Garnier-Suillerot A.. Permeability of Lipid Bilayer to Anthracycline Derivatives. Role of the Bilayer Composition and of the Temperature. Biochim. Biophys. Acta, Lipids Lipid Metab. 1998;1389(1):13–22. doi: 10.1016/S0005-2760(97)00070-2. [DOI] [PubMed] [Google Scholar]
- Tasca E., Alba J., Galantini L., D’abramo M., Giuliani A. M., Amadei A., Palazzo G., Giustini M.. The Self-Association Equilibria of Doxorubicin at High Concentration and Ionic Strength Characterized by Fluorescence Spectroscopy and Molecular Dynamics Simulations. Colloids Surf., A. 2019;577:517–522. doi: 10.1016/j.colsurfa.2019.06.005. [DOI] [Google Scholar]
- Despa F., Berry R. S.. The Origin of Long-Range Attraction between Hydrophobes in Water. Biophys. J. 2007;92(2):373–378. doi: 10.1529/biophysj.106.087023. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Meyer E. E., Rosenberg K. J., Israelachvili J.. Recent Progress in Understanding Hydrophobic Interactions. Proc. Natl. Acad. Sci. U. S. A. 2006;103(43):15739–15746. doi: 10.1073/pnas.0606422103. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Martinez C. R., Iverson B. L.. Rethinking the Term “Pi-Stacking. Chem. Sci. 2012;3(7):2191. doi: 10.1039/c2sc20045g. [DOI] [Google Scholar]
- Rosen, M. J. ; Kunjappu, J. T. . Surfactants and Interfacial Phenomena; 1st ed., Wiley; 2012. 10.1002/9781118228920 [DOI] [Google Scholar]
- Lima E. C., Gomes A. A., Tran H. N.. Comparison of the Nonlinear and Linear Forms of the van’t Hoff Equation for Calculation of Adsorption Thermodynamic Parameters (ΔS° and ΔH°) J. Mol. Liq. 2020;311:113315. doi: 10.1016/j.molliq.2020.113315. [DOI] [Google Scholar]
- Wang H., Chen J., Xu C., Shi L., Tayier M., Zhou J., Zhang J., Wu J., Ye Z., Fang T., Han W.. Cancer Nanomedicines Stabilized by π-π Stacking between Heterodimeric Prodrugs Enable Exceptionally High Drug Loading Capacity and Safer Delivery of Drug Combinations. Theranostics. 2017;7(15):3638–3652. doi: 10.7150/thno.20028. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lee H., Larson R. G.. Adsorption of Plasma Proteins onto PEGylated Lipid Bilayers: The Effect of PEG Size and Grafting Density. Biomacromolecules. 2016;17(5):1757–1765. doi: 10.1021/acs.biomac.6b00146. [DOI] [PubMed] [Google Scholar]
- Nicholas A. R., Scott M. J., Kennedy N. I., Jones M. N.. Effect of Grafted Polyethylene Glycol (PEG) on the Size, Encapsulation Efficiency and Permeability of Vesicles. Biochim. Biophys. Acta. 2000;1463(1):167–178. doi: 10.1016/S0005-2736(99)00192-3. [DOI] [PubMed] [Google Scholar]
- Shoemaker S. D., Vanderlick T. K.. Intramembrane Electrostatic Interactions Destabilize Lipid Vesicles. Biophys. J. 2002;83(4):2007–2014. doi: 10.1016/S0006-3495(02)73962-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Noppl-Simson D. A., Needham D.. Avidin-Biotin Interactions at Vesicle Surfaces: Adsorption and Binding, Cross-Bridge Formation, and Lateral Interactions. Biophys. J. 1996;70(3):1391–1401. doi: 10.1016/S0006-3495(96)79697-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chen C., Zhou Y., Chen C., Zhu S., Yan X.. Quantification of Available Ligand Density on the Surface of Targeted Liposomal Nanomedicines at the Single-Particle Level. ACS Nano. 2022;16(4):6886–6897. doi: 10.1021/acsnano.2c02084. [DOI] [PubMed] [Google Scholar]
- Teeguarden J. G., Hinderliter P. M., Orr G., Thrall B. D., Pounds J. G.. Particokinetics In Vitro: Dosimetry Considerations for In Vitro Nanoparticle Toxicity Assessments. Toxicol. Sci. 2007;95(2):300–312. doi: 10.1093/toxsci/kfl165. [DOI] [PubMed] [Google Scholar]
- Atkins, P. W. ; de Paula, J. ; Keeler, J. J. . Atkins’ Physical chemistry; Aufl. Oxford Univ. Press: Oxford, 2018; p 11. [Google Scholar]
- Hu W., Mao A., Wong P., Larsen A., Yazaki P. J., Wong J. Y. C., Shively J. E.. Characterization of 1,2-Distearoyl- Sn -Glycero-3-Phosphoethanolamine– N -[Methoxy(Polyethylene Glycerol)-2000] and Its Complex with Doxorubicin Using Nuclear Magnetic Resonance Spectroscopy and Molecular Dynamics. Bioconjugate Chem. 2017;28(6):1777–1790. doi: 10.1021/acs.bioconjchem.7b00238. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Henry N., Fantine E. O., Bolard J., Garnier-Suillerot A.. Interaction of Adriamycin with Negatively Charged Model Membranes: Evidence of Two Types of Binding Sites. Biochemistry. 1985;24(25):7085–7092. doi: 10.1021/bi00346a010. [DOI] [PubMed] [Google Scholar]
- Solomonov B. N., Sedov I. A.. The Hydrophobic Effect Gibbs Energy. J. Mol. Liq. 2008;139(1–3):89–97. doi: 10.1016/j.molliq.2007.11.004. [DOI] [Google Scholar]
- Neacşu A.. Physicochemical Investigation of the Complexation between γ-Cyclodextrin and Doxorubicin in Solution and in Solid State. Thermochim. Acta. 2018;661:51–58. doi: 10.1016/j.tca.2018.01.012. [DOI] [Google Scholar]
- Woods C. J., Malaisree M., Michel J., Long B., McIntosh-Smith S., Mulholland A. J.. Rapid Decomposition and Visualisation of Protein–Ligand Binding Free Energies by Residue and by Water. Faraday Discuss. 2014;169:477–499. doi: 10.1039/C3FD00125C. [DOI] [PubMed] [Google Scholar]
- Su P., Liu H., Wu W.. Free Energy Decomposition Analysis of Bonding and Nonbonding Interactions in Solution. J. Chem. Phys. 2012;137(3):034111. doi: 10.1063/1.4736533. [DOI] [PubMed] [Google Scholar]
- Siani P., Donadoni E., Ferraro L., Re F., Di Valentin C.. Molecular Dynamics Simulations of Doxorubicin in Sphingomyelin-Based Lipid Membranes. Biochim. Biophys. Acta. 2022;1864(1):183763. doi: 10.1016/j.bbamem.2021.183763. [DOI] [PubMed] [Google Scholar]
- Ki̇li̇c S.. Effect of Temperature on Stability of Lipid Microbubbles. J. Turk. Chem. Soc. A: Chem. 2019;6(3):439–450. doi: 10.18596/jotcsa.594219. [DOI] [Google Scholar]
- Fearon A. D., Stokes G. Y.. Thermodynamics of Indomethacin Adsorption to Phospholipid Membranes. J. Phys. Chem. B. 2017;121(46):10508–10518. doi: 10.1021/acs.jpcb.7b08359. [DOI] [PubMed] [Google Scholar]
- Smith G. D., Bedrov D., Borodin O.. Conformations and Chain Dimensions of Poly(Ethylene Oxide) in Aqueous Solution: A Molecular Dynamics Simulation Study. J. Am. Chem. Soc. 2000;122(39):9548–9549. doi: 10.1021/ja001053j. [DOI] [Google Scholar]
- Tirosh O., Barenholz Y., Katzhendler J., Priev A.. Hydration of Polyethylene Glycol-Grafted Liposomes. Biophys. J. 1998;74(3):1371–1379. doi: 10.1016/S0006-3495(98)77849-X. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sukenik S., Sapir L., Harries D.. Balance of Enthalpy and Entropy in Depletion Forces. Curr. Opin. Colloid Interface Sci. 2013;18(6):495–501. doi: 10.1016/j.cocis.2013.10.002. [DOI] [Google Scholar]
- Hamal P., Subasinghege Don V., Nguyenhuu H., Ranasinghe J. C., Nauman J. A., McCarley R. L., Kumar R., Haber L. H.. Influence of Temperature on Molecular Adsorption and Transport at Liposome Surfaces Studied by Molecular Dynamics Simulations and Second Harmonic Generation Spectroscopy. J. Phys. Chem. B. 2021;125(37):10506–10513. doi: 10.1021/acs.jpcb.1c04263. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Comiskey S. J., Heath T. D.. Serum-Induced Leakage of Negatively-Charged Liposomes at Nanomolar Lipid Concentrations. Biochemistry. 1990;29(15):3626–3631. doi: 10.1021/bi00467a006. [DOI] [PubMed] [Google Scholar]
- Deng Z., Yan F., Jin Q., Li F., Wu J., Liu X., Zheng H.. Reversal of Multidrug Resistance Phenotype in Human Breast Cancer Cells Using Doxorubicin-Liposome–Microbubble Complexes Assisted by Ultrasound. J. Controlled Release. 2014;174:109–116. doi: 10.1016/j.jconrel.2013.11.018. [DOI] [PubMed] [Google Scholar]
- Cabral H., Kataoka K.. Progress of Drug-Loaded Polymeric Micelles into Clinical Studies. J. Controlled Release. 2014;190:465–476. doi: 10.1016/j.jconrel.2014.06.042. [DOI] [PubMed] [Google Scholar]
- Fisher N. G., Christiansen J. P., Klibanov A., Taylor R. P., Kaul S., Lindner J. R.. Influence of Microbubble Surface Charge on Capillary Transit and Myocardial Contrast Enhancement. J. Am. College Cardiol. 2002;40(4):811–819. doi: 10.1016/S0735-1097(02)02038-7. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
